ABSTRACT
Aims/hypothesis Observational evidence suggests a shared etiology between impaired glucose tolerance, cardiovascular risk, and fertility problems. We aim to establish whether impaired glucose tolerance (as measured by fasting glucose, glycated hemoglobin, and fasting insulin) and cardiovascular disease risk (as measured by LDL cholesterol, HDL cholesterol, triglycerides, systolic blood pressure, and diastolic blood pressure) are causally related to infertility (having tried to conceive for ≥ 12 months or used assisted reproduction technologies to conceive) by Mendelian randomization (MR) analyses in women and men.
Methods We conducted two-sample MR analyses, in which we used genome-wide association summary data that were publicly available for the cardiometabolic risk factors, and sex specific genome-wide association studies of infertility conducted in the Norwegian Mother, Father, and Child Cohort Study (68,882 women [average age 30, involved in 81,682 pregnancies] and 47,474 of their male partners [average age 33, 55,744 pregnancies]). We applied the inverse variance weighted method with random effects to pool data across variants and a series of sensitivity analyses to explore genetic instrument validity (we checked the robustness of genetic instruments and the lack of unbalanced horizontal pleiotropy, and we used methods that are robust to population stratification). Findings were corrected for multiple comparisons by the Bonferroni method (8 exposures: p-value < 0.00625).
Results In women, increases in genetically determined fasting insulin levels were associated with greater odds of infertility (+1 log(pmol/L): OR 1.60, 95% CI 1.17 to 2.18, p-value = 0.003). The results were robust in the sensitivity analyses exploring the validity of MR assumptions and the role of pleiotropy of other cardiometabolic risk factors. There was also evidence of higher glucose and glycated hemoglobin in women (and possibly higher fasting insulin in men) causing infertility, but findings were imprecise and did not pass our p-value threshold for multiple testing. Results for lipids and blood pressure were close to the null, suggesting that these did not cause infertility.
Conclusions/interpretation Genetic instruments suggest that higher fasting insulin may increase infertility in women.
TWEET Mendelian randomization suggests that higher fasting #insulin levels increase the risk of #infertility in women. @alvaro_hernaez @theCEFH @Folkehelseinst @ERC_Research #MendelianRandomization
What is already known about this subject?
Observational evidence suggests impaired glucose tolerance, higher lipid concentrations, and higher blood pressure is associated with fertility problems.
What is the key question?
Are fasting glucose, glycated hemoglobin, fasting insulin, LDL cholesterol, HDL cholesterol, triglycerides, systolic blood pressure, and diastolic blood pressure causally related to infertility in women and men?
What are the new findings?
Two-sample Mendelian randomization suggests that higher fasting insulin levels increase the risk of infertility in women. There was also evidence of higher glucose and glycated hemoglobin in women (and maybe higher fasting insulin in men) causing infertility, but results were imprecise and did not pass our p-value threshold for multiple comparisons.
Findings for lipids and blood pressure were close to the null, suggesting that these did not have a causal role on infertility.
How might this impact on clinical practice in the foreseeable future?
Treatments to lower fasting insulin levels may reduce the risk of infertility in women.
Competing Interest Statement
D.A.L. receives (or has received in the last 10 years) research support from National and International government and charitable bodies, Roche Diagnostics and Medtronic for research unrelated to the current work. O.A.A. is or has been in the last 10 years consultant to HealthLytix. The rest of the authors declare that no competing interests exist.
Funding Statement
The MoBa Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Norwegian Ministry of Education and Research. This project received funding from the European Research Council under the European Union Horizon 2020 research and innovation program (grant agreement No 947684). This work was also partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 262700, and the project Women fertility. An essential component of health and well-being, number 320656, and co-funded by the European Research Council (grant agreement No 101071773). Open Access funding was provided by the Norwegian Institute of Public Health. P.R.N. was supported by the European Research Council (grant agreement No 293574). E.C. and A.Havdahl were supported by the Research Council of Norway (274611) and the South-Eastern Norway Regional Health Authority (project numbers 2020022, 2021045). D.A.L. is a UK National Institute for Health Research Senior Investigator (NF/SI/0611/10196) and was supported by the British Heart Foundation (CH/F/20/90003 and AA/18/1/34219) and the European Research Council (grant agreement No 101021566). The funders had no role in the study design; the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. Views and opinions expressed in this paper are those of the authors only and do not necessarily reflect those of the funders. Neither the European Union nor the granting authority can be held responsible for them.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The MoBa study follows the Declaration of Helsinki for Medical Research involving human subjects. The establishment of MoBa and its initial data collection were based on a license from the Norwegian Data Protection Agency and approved by Regional Committees for Medical and Health Research Ethics. The MoBa cohort is now based on the regulations in the Norwegian Health Registry Act. Participants provided written informed consent before joining the cohort. This project was approved by the Regional Committee for Medical and Health Research Ethics of South/East Norway (reference: 2017/1362).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The consent given by the participants does not allow for storage of individual data in repositories or journals. Researchers who want access to data sets for replication should apply through datatilgang{at}fhi.no. This process requires approval from the Regional Committee for Medical and Health Research Ethics in Norway and an agreement with MoBa. GWAS summary statistics on fasting glucose, glycated hemoglobin, and fasting insulin have been contributed by the Meta-Analyses of Glucose and Insulin-related traits Consortium investigators and have been downloaded from https://magicinvestigators.org/downloads/ (menu: Trans-ancestry and single-ancestry meta-analysis summary statistics of four glycemic traits). GWAS summary statistics on lipid profile traits have been contributed by the Global Lipids Genetics Consortium investigators and have been downloaded from http://csg.sph.umich.edu/willer/public/glgc-lipids2021/ (menu: Ancestry-specific GWAS summary statistics for HDL-C, LDL-C, nonHDL-C, TC and TG). Finally, GWAS summary statistics on blood pressure have been contributed by Evangelou E et al. and have been downloaded from the Supplemental Tables of the article (https://www.nature.com/articles/s41588-018-0205-x#MOESM3).
ABBREVIATIONS
- DBP
- diastolic blood pressure
- GWAS
- genome-wide association study
- HDL-C
- high-density lipoprotein cholesterol
- LDL-C
- low-density lipoprotein cholesterol
- MoBa
- Mother, Father and Child Cohort Study
- MR
- Mendelian randomization
- SBP
- systolic blood pressure
